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Targeted Alpha Therapy potentially offers a more specific action in killing tumor cells and less
damage to neighbouring normal cells compared to β-emitters. 225Ac along with three other α-
emitting daughter nuclei 221Fr, 217At and 213Po have significant potency for clinical use. Monte
carlo simulation has been carried out using MONC code for production routes of 225Ac for its
possible generation using proton accelerators with Thorium-232 and Radium-226 targets. All the
calculations has been carried out using global model parameters without adjusting for individual
target. The study reveals that proton beam of 20-30MeV energy with 5µA current on radium-
226 target can give rise to 1Ci of 225Ac activity in a week of irradiation. Thorium irradiation at
low proton energy produces smaller 225Ac activity but one can benefit from high current, stable
proton accelerators. Proton energy of 100MeV or above with hundreds of µA current can produce
reasonable 225Ac activity for practical use. However, the contamination of other co-produced radio-
isotopes is much less at low proton energy hence low energy high current proton accelerators are
also viable alternative to generate Actinium-225 radio isotope.
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I. INTRODUCTION
Radio-isotope production by different methods, chem-
ical seperation, isotope delivery, molecular targets, radi-
olabeling protocols and identification of clinical applica-
tions are an active area of research. Several β-emitters,
90Y (t1/2=2.67d) and
131I (t1/2=8.07d) emit electrons
with maximum kinetic energies of 0.32.3 MeV with a
range of ∼0.5 - 12 mm in tissues. Single cell disease such
as leukemia, micrometastases, post-surgical residual dis-
ease and some other types of cancer may not be curable
with targeted β-particle therapy due to insufficient dose
to each cell [1]. Concomitantly, a significant portion of
the dose would also be deposited in the surrounding nor-
mal tissues by virtue of long range. Therefore α-particle
targeted therapy provides superior option compared to
β-particle therapy. Production of 225Ac has been stud-
ied for its possible generation using proton accelerator.
Heavy ions have larger linear energy transfer and
smaller penetration depth which lead to targeted killing
of the cancer cell. Carbon therapy is becoming popular
after proton therapy due to larger linear energy transfer.
Targeted Alpha Therapy (TAT) is one of the promising
and effective methods for treatment of bladder cancer,
brain tumors, neuroendocrine tumors and prostate can-
cer due to short range (47-85µm) [2, 3] of alpha parti-
cles. The linear energy transfer from alpha particles is
two orders of magnitude higher than that by β-particle.
Single α-emitter such as 213Bi eluted from 225Ac or 225Ac
∗author. Email address: harphool@barc.gov.in
with 4-α emitting isotopes along with radio-isotopes from
its decay chain are currently under immense interest for
treating several malignant diseases even acute myeloid
leukemia. 225Ac and daughter isotopes with 4-α’s give
1000 times more integrated dose compared to single al-
pha from 213Bi[4]. Relative biological effectiveness is 3-8
times higher for alpha particles [5]. Although, 225Ac is
superior α-emitting source but the fate of the free daugh-
ter radioisotopes in circulation after decay is to be re-
solved thoroughly.
Alpha emitters such as 225Ac are favorable due to
their very short range (few cell diameters) and tar-
geted high doses to kill cancer cells which show resis-
tance to treatment with beta- or gamma- irradiation or
chemotherapeutic drugs. Some of the gamma emission
(221Fr, 218.2keV, 11.6%; 213Bi, 440.5keV, 26.1%; 209Tl,
117.2keV, 84.3%, 465.1keV, 96.9%, 1567.1keV, 99.8%;)
from the decay chain of the 225Ac along its path gives
in vivo imaging and pharmaco-kinetic and dosimetric
studies [6]. Long half-life of 225Ac and the multiple al-
pha particles generated in the decay chain render 225Ac a
particularly cyto-toxic radio-nuclide. Reactor based pro-
duction of 225Ac by decay of 229Th (T1/2=7880y) is avail-
able from few places like ORNL, USA, IPPE, Obninsk,
Russia and ITU, Germany with combined inventory of
∼1.8Ci/year[7]. There are plan to develop advance reac-
tor system with 232Th utilization [8]. This reactor can
generate 229Th which can give 225Ac through α-decay.
Several studies have been conducted to investigate dif-
ferent means of increasing the available supply of either
229Th parent or 225Ac itself. 225Ac can be produced by
proton+232Th reaction at high energy spallation reaction
as a direct product as well as it can be milked from 229Pa
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2at low energies. 229Pa decays via emitting α-particle to
225Ac with only 0.48% branching ratio and rest decays to
229Th. Thus, producing required quantities of 225Ac ac-
tivity using low energy proton accelerator from 229Th is
challenging due to its extremely long half-life despite the
∼160 mb cross section for the 232Th(p, 4n)229Pa reaction
at ∼30 MeV. Dedicated accelerator production of 229Th
may not be economically viable due to long irradiation
times and high currents required to produce a substantial
quantity of 229Th [9].
Cross-section were measured at ITU, Germany for
226Ra(p, 2n)225Ac to seek direct production of this iso-
tope [10]. The cross-section peaks (∼ 700mb) around
17MeV proton energy. A feasibility study of the 226Ra(γ,
2n)225Ra reaction for producing the 225Ra, the parent to
225Ac, has revealed that 225Ra yields are insignificant for
practical use [11].
In this paper, activity of 225Ac is estimated for
p+232Th and p+226Ra reactions at low proton ener-
gies. A comparative study for the production of 225Ac
by Thorium-232 target at different energies is performed
to search an optimum energy. Monte-carlo code MONC
(MOnte carlo Nucleon transport Code) [12–16] is used
for the present simulation. In Sec. II, we present small
description of MONC. Section III contains simulation
studies for production of 225Ac. Conclusions are given
in Sec. IV.
II. DESCRIPTION OF MONC
Monte Carlo program MONC incorporates Intra-
nuclear Cascade, Pre-equilibrium, Evaporation and Fis-
sion models to simulate spallation reaction mechanism
for thin and thick targets. Modeling details of Intra-
nuclear cascade, pre-equilibrium particle emission are de-
scribed in detail in Ref. [16]. Treatment of cutoff en-
ergy from Intra-nuclear to pre-equilibrium and next to
evaporation stage was changed later which is described
in Ref. [12]. Generalized evaporation model was devel-
oped as described in Ref. [17]. Fission barrier, level
density parameter and inverse cross sections for pre-
equilibrium/evaporation/fission model are given in detail
in Ref. [12, 13]. The following level density parameters
are used in MONC.
a = (0.134− .000121A)(1 + (1− e−0.061E)∆S/E) (1)
Where ∆S is shell correction, E is excitation energy and
A is Mass number of the compound nucleus. Bench-
mark of spallation models for experimental values of neu-
tron, charged particles, and pions double differential pro-
duction cross-sections, particle multiplicities, spallation
residues and excitation functions was organized by IAEA
and is given in Ref. [18]. We have used the predecessor of
this code named CASCADE.04 to calculate these quan-
tities in the benchmark. Heat Deposition algorithm for
thick spallation targets and thin films was modified and
benchmarked as mentioned in Ref. [19]. The code was
further developed for the Neutron shielding and dosime-
try applications [20]. The code can be used for single
nucleus interaction in basic reaction studies and can be
invoked for the thick target simulation during the trans-
port. Energy loss of the charged particle is calculated
during the transport in the thick target.
Point data is used for the low energy neutron transport
as described in [14, 15]. The processing of ENDF/B neu-
tron data library and generation of point data at required
temperature is inherent feature of the code. Linear chain
method is implemented to solve the Bateman’s[21] gen-
eral solution for decay and build-up of isotope invento-
ries. ENDF-decay data library is used for the decay prop-
erties of different radio-active isotopes.
III. PRODUCTION OF ACTINIUM
The production of 225Ac at low energy is governed by
generation of 229Pa through 232Th(p, 4n)229Pa reaction.
The reaction for production of 229Pa as given in Eq. 2,
has a threshold of ∼19.5MeV. Direct production of 225Ac
starts at higher energies. The cross-section for direct
production of 225Ac at low energies is rather low but it
is generated by decay of 229Pa through direct α decay
with 0.48% branching ratio; rest of it decays through β−
decay to 229Th. Full decay chain is given in Fig. 1. The
decay products of the 225Ac are also α-emitters untill it
gives 209Bi as stable isotope.
p+232 Th⇒ 4n+229 Pa(∆Q = −19.446MeV ) (2)
It is clear from Fig. 1 that α decay branching ratio lead-
ing to production of 225Ac in a short span of time is
only 0.48% and remaining 99.52% goes to 229Th which
has long half life of 7340 years and is also available from
weapons program or reactors. In case of reactor based
production from Thorium, the route is given as
{n+232 Th⇒233 Th⇒233 U + β−
⇒229 Th+ α⇒225 Ra+ α⇒225 Ac+ β−} (3)
In order to have quantitative estimate of 225Ac activ-
ity produced by proton+232Th system, total reaction and
individual channel cross-sections are calculated and com-
pared with experimental data. The optimum energy from
proton+232Th reaction cross-section point of view is ∼
150MeV which is shown in Fig.2. The low energy proton
accelerators with higher current are easy to build com-
pared to high energy accelerators so we have studied the
production of 225Ac by low energy proton beam.
Economical production of 225Ac would require thick
target irradiation leading to energy loss of the primary
proton energy. The energy loss shows a range of ∼2mm
and ∼16mm at 30MeV and 100MeV proton energies for
Thorium target, as shown in Fig.3. The energy of the
primary proton also changes along its path in thick target
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FIG. 1: Decay chain of 225Ac.
FIG. 2: Reaction cross-section for Proton+232Th system us-
ing MONC
due to continuous energy loss. The secondary protons
undergoing nuclear reaction are shown in Fig. 4.
More than 99% energy is deposited as heat at 30MeV
which reduces to ∼96% at 100MeV for complete beam
dump. The Temperature rise of Thorium metal of diam-
eter 10cm and thickness 2mm after one hour irradiation
FIG. 3: Heat deposition and range of proton in 232Th target
for 100MeV and 30MeV proton energies.
FIG. 4: Proton energy distribution after energy loss in thick
232Th target.
of 30MeV proton beam with one µA current is calculated
using the following rather simple Eq.4 without consider-
ing any cooling.
ms∆T = Q(Heat) (4)
4FIG. 5: Excitation function/production cross-section for the
232Th(p, X)229Pa reaction.
FIG. 6: Excitation function/production cross-section for the
232Th(p, X)229Th reaction.
Here, s=0.12J/gK is specific heat of Thorium metal,
m is mass and Q is heat deposited by proton beam. The
temperature comes out to be 5000K which demands ded-
icated cooling of the target if it is used as beam dump.
A small amount of Thorium as thin foil can be irradiated
to avoid such large heating.
Individual channel cross-section in MONC are based
on the isotope production cross-section but not identi-
fication of channel in particular. The excitation func-
tion for the production of 229Pa, 229Th and 225Ac for
p+232Th system are compared with experimental data in
Figs.5, 6, 7, respectively. The cross-section data for 229Pa
are taken from EXFOR data base maintained by IAEA
[22, 23]. The estimation from MONC for this isotope
compared well at low energies of current interest but it
overestimates between 50MeV to 100MeV range. Direct
production of 229Th leading to 225Ac with long half life
also has significant cross-section [23] which is very well
reproduced by MONC, although it has only single mea-
FIG. 7: Excitation function/production cross-section for the
232Th(p, X)225Ac (cumulative yield) reaction.
FIG. 8: Production of 225Ac and its α-emitter decay products
after different irradiation time using proton beam of 30MeV
with 1µA current for p+232Th system
.
sured data point reported. Direct production of 225Ac
has higher threshold and the measured cross-section [24?
–26] is also low. It should be noted that experimental
data are derived from cumulative yield but MONC cal-
culations are for independent yields. The measured data
for independent yield are given by [27] and depicted in
the Fig.7 by solid circles. It is to be noted that MONC
compared well with these data points although the differ-
ence in cumulative and independent data is rather small.
After comparing the cross-section and heat deposition,
produced activity for a thick target are estimated at
different irradiation time periods. Simulation was per-
formed for full beam deposition. Production of 225Ac in
MBq per µA proton current of 30MeV energy and it’s
daughter products which are also α-emitters are given in
Fig.8. The combined activity for 10 days irradiation is ∼
5TABLE I: Contribution of different decay channel in forming
225Ac at 30MeV proton energy for p+232Th system.
Target Thickness (mm) Parent nucleus % share
1.0 229Th 6.4452139E-08
1.0 233Th 8.5865402E-15
1.0 229Pa 0.999999936
1.0 229Th 8.9715132E-14
TABLE II: Production of 225Ac for 1µA proton beam current
of different energies, 1mm target thickness and for different
irradiation times.
Target Thickness Activity Irradiation Energy
(mm) (MBq/µA) (Days) (MeV)
232Th 1.0 5.2 10 30
232Th 1.0 9 20 30
232Th 1.0 11 30 30
232Th 1.0 83 10 100
226Ra 1.0 1643 10 20
226Ra 1.0 2465 20 20
226Ra 1.0 2876 30 20
226Ra 1.0 1709 10 30
20MBq per µA which can be increased to 2GBq for 100
µA current. The main contributor of this production is
229Pa isotope as shown in Table I.
A comparative study for full proton beam dump in
232Th target shows significantly increased activity of
225Ac with energy as the cross-section for direct produc-
tion of 225Ac increases with proton energy. The activity
continuously increases with increase in energy as shown
Fig.9. Ratio of 225Ac activity at 100MeV and 30MeV
shows a gain of ∼ 100 for complete dump of the beam.
The gain factor for 300MeV compared to 100MeV is ∼ 80
for full beam dump in the target as shown in Fig.10. Al-
though there is an increase in activity with proton energy
increment but energy spent per MBq of 225Ac produced
in this reaction as shown in Fig.11, shows that higher en-
ergies are not attractive as no significant gain in activity
after 300MeV which may be termed as most optimum
energy.
Other reaction channel with 226Ra as target material
which gives rise to 225Ac at rather low energy is as follows
p+226 Ra⇒ 2n+225 Ac(∆Q = −6.823MeV ) (5)
The production cross-sections/excitation function are
compared with the experimental data [10] for this re-
action as given in Fig.12. The area under peak is in good
agreement with the experimental data with slight shift
in the peak position. The activity (MBq/µA) of 225Ac
is compared in Table II for 1mm thick 232Th and 226Ra
targets at different beam energies and irradiation times.
It is clear from Table II that the 226Ra target can give
much higher activity compared to 232Th target and it is
also much cleaner from co-produced radio isotopes. The
Activity of the four α-emitting isotopes is compared as
FIG. 9: Production of 225Ac at different energies with 1µA
current for p+232Th system
shown in Fig.13 where the combined activity may meet
the demand of the world community.
IV. CONCLUSION
The cross-section of different channel reactions
p+232Th systems has been calculated with MONC code
and compared with experimental data and the results
are in good agreement. Further, production of 225Ac
is analysed at different proton energies for 232Th tar-
get material for full beam dump and 1mm thick targets.
There are many challenging tasks like removal of other
Actinium isotopes and others which may be difficult to
separate. The production of 225Ac activity is very high
for 226Ra target and seems very promising from practical
and economical use, whereas availability and handling
of Radium-226 target might be a challenge. The pro-
duced activity of 225Ac in a week of irradiation through
226Ra target may be equal to present total annual pro-
6FIG. 10: Relative yield of 225Ac at 30MeV, 100MeV, and
500MeV for 1µA current for p+232Th system.
FIG. 11: proton energy spent per micro gram production of
225Ac for one and 10 day accelerator operation with 1µA cur-
rent for p+232Th system.
duction by milking 229Th. Thorium yields smaller 225Ac
activity at low proton energies (∼30MeV) but one can
be benefited from higher current, stable proton accelera-
tors. Proton energy of 100MeV or above with hundreds
of µA current can produce reasonable 225Ac activity for
practical use. The contamination of other co-produced
radio-isotopes is much less at low proton energies hence
FIG. 12: calculated reaction 226Ra(p,2n)225Ac cross-section
using MONC
FIG. 13: Production of 225Ac and its α−emitter decay prod-
ucts after different irradiation time using p(30MeV) + 232Th
and p(20MeV) + 226Ra with 1µA current
low energy high current proton accelerators might also
be a viable alternative to generate Actinium-225 radio
isotope using 232Th target.
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